Biomedical Engineering Reference
In-Depth Information
Frijns, C.J.M. and K.J. Kappelle. 2002. Inl ammatory cell adhesion molecules in ischemic
cerebrovascular disease. Stroke 33: 2115-2122.
Hassan, A. and B.J. Hunt, M. O'Sullivan, K. Parmar, J.M. Bamford, D. Briley, M.M. Brown,
D.J. h omas, and H.S. Markus. 2003. Markers of endothelial dysfunction in lacunar
infarction and ischemic leukoaraiosis. Brain 126: 424-432.
Hoshi, T. and K. Kitagawa, H. Yamagami, S. Furukado, H. Hougaku, and M. Hori. 2005.
Relations of serum high-sensitivity C-reactive protein and interleukin-6 levels with
silent brain infarction. Stroke 36: 768-772.
Huang, Y. and Y. Cheng, J. Wu, Y. Li, E. Xu, Z. Hong, Z. Li, W. Zhang, M. Ding, X. Gao, D.
Fan, J. Zeng, K. Wong, C. Lu, J. Xiao, and C. Yao. 2008. Cilostazol as an alternative to
aspirin at er ischaemic stroke: a randomized, double-blind, pilot study. Lancet Neurol.
7: 494-499.
Hwang, S.J. and C.M. Ballantyne, A.R. Sharrett, L.C. Smith, C.E. Davis, A.M. Gotto, and E.
Boerwinkle. 1997. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin
in carotid atherosclerosis and incident coronary heart disease cases. h e Atherosclerosis
Risk In Communities (ARIC) Study. Circulation 96: 4219-4225.
Ishikawa, J. and Y. Tamura, S. Hoshide, K. Eguchi, S. Ishikawa, K. Shimada, and K. Kario.
2007. Low-grade inl ammation is a risk factor for clinical stroke events in addition to
silent cerebral infarcts in Japanese older hypertensives. h e Jichi Medical School ABPM
Study, Wave 1. Stroke 38: 911-917.
Ishikawa, M. and D. Cooper, T.V. Arumugam, J.H. Zhang, A. Nanda, and D.N. Granger.
2004. Platelet-leukocyte-endothelial cell interactions at er middle cerebral artery
occlusion and reperfusion. J. Cereb. Blood Flow Metab. 24: 907-915.
Kanai, A. and T. Kawamura, T. Umemura, M. Nagashima, N. Nakamura, M. Nakayama, T.
Sano, E. Nakashima, Y. Hamada, J. Nakamura, and N. Hotta. 2008. Association between
future events of brain infarction and soluble levels of intercellular adhesion molecule-1
and C-reactive protein in patients with type 2 diabetes mellitus. Diabet. Res. Clin. Pract.
82: 157-164.
Kawamura, T. and T. Umemura, A. Kanai, M. Nagashima, N. Nakamura, T. Uno, M.
Nakayama, T. Sano, Y. Hamada, J. Nakamura, and N. Hotta. 2006. Soluble adhesion
molecules and C-reactive protein in the progression of silent cerebral infarction in
patients with type 2 diabetes mellitus. Metabolism 55: 461-466.
Kumar, S. and S. Savitz, G. Schlaug, L. Caplan, and M. Selim. 2006. Antiplatelets, ACE
inhibitors, and statins combination reduces stroke severity and tissue at risk. Neurology
66: 1153-1158.
Lindsberg, P.J. and O. Carpén, A. Paetau, M.L. Karjalainen-Lindsberg, and M. Kaste. 1996.
Endothelial ICAM-1 expression associated with inl ammatory cell response in human
ischemic stroke. Circulation 94: 939-945.
Markus, H.S. and B. Hunt, K. Palmer, C. Enzinger, H. Schmidt, and R. Schmidt. 2005.
Markers of endothelial and hemostatic activation and progression of cerebral white
matter hyperintensities. Longitudinal Results of the Austrian Stroke Prevention Study.
Stroke 36: 1410-1414.
Marfella, R. and K. Esposito, R. Giunta, G. Coppola, L.D. Angelis, B. Farzati, G. Paolisso, and
D. Giugliano. 2000. Circulating adhesion molecules in humans. Role of hyperglycemia
and hyperinsulinemia. Circulation 101: 2247-2251.
